This article was originally published in The Gray Sheet
Executive SummaryThomas Spackman, MD, named president and CEO of the medical imaging systems manufacturer, as well as senior VP of Israeli parent Eiscint Ltd., effective Dec. 13. The posts have been vacant for over a year. Spackman currently is director, Department of Radiology at the St. Francis Hospital and Medical Center in Hartford, Connecticut.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
An AAM-sponsored study by researcher Avalere Health has concluded that Medicare Part D policy changes have led to generics being placed on non-generic tiers 53% of the time in 2020, with generics placed on the ‘preferred generic’ Tier 1 just 10% of the time.